Position history for Lido Advisors, LLC's holdings in Catalyst Pharmaceuticals Inc
Lido Advisors, LLC holds 26,841 shares of CPRX (Catalyst Pharmaceuticals Inc), worth $664,583 as of 2026-Q1. The position was decreased (-5.8% shares). CPRX represents 0.0% of Lido Advisors, LLC's portfolio.
Current Value
$664,583
Current Shares
26,841
Total Value Change
+$436,586
Total Shares Change
+12,122
Other major holders of CPRX: BlackRock, Inc.
Decreased |
| 26,841 |
-5.8% |
| $664,583 |
| 0.0% |
| $23.92 |
0 |
| 2025-Q4 | Unchanged | 28,505 | 0.0% | $561,549 | 0.0% | $23.29 | 0 |
| 2025-Q3 | Increased | 28,505 | +16.7% | $561,549 | 0.0% | $19.55 | 28 |
| 2025-Q2 | Decreased | 24,422 | -0.8% | $529,958 | 0.0% | $21.78 | 0 |
| 2025-Q1 | Decreased | 24,612 | -0.2% | $596,842 | 0.0% | $24.69 | 0 |
| 2024-Q4 | Increased | 24,658 | +12.0% | $514,612 | 0.0% | $21.07 | 27 |
| 2024-Q3 | Increased | 22,008 | +49.5% | $437,519 | 0.0% | $19.56 | 33 |
| 2024-Q2 | Increased | 14,719 | +0.5% | $227,997 | 0.0% | $15.49 | 23 |